Results 101 to 110 of about 4,832 (178)

Safety and effectiveness of benralizumab in Indian patients with severe eosinophilic asthma: results from the FAST study. [PDF]

Front Med (Lausanne)
Talwar D, Maturu VN, Meshram PL, Mittal S, Praveen JV, Guleria R, Kumar A, Agarwal A, Verma AK, Mohan M, Narasimhan R, Jain N, Sharma R, Kumar R, Parakh U, Momi G.   +15 more
europepmc   +1 more source

Clinical Remission in Patients with Severe Eosinophilic Asthma - A Single-Arm Observational Study with Benralizumab. [PDF]

J Asthma Allergy
Pavlov N, Bridevaux PO, Jandus P, Charbonnier F, Schuoler C, Wörner PM, Leuppi JD, Rothe T, Stolz D.   +8 more
europepmc   +1 more source

Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study. [PDF]

J Asthma Allergy
Adrish M, DeMartino JK, Carstens D, Jackson M, Schinkel J, Wilson K, Tkacz J.   +6 more
europepmc   +1 more source

Blood eosinophil count as a biomarker for therapy guidance in COPD and asthma exacerbations. [PDF]

Breathe (Sheff)
Godallage AN, Afrose D, Valizadeh M, Beech A, Jensen JS, Sivapalan P.   +5 more
europepmc   +1 more source

Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis. [PDF]

ERJ Open Res
Mukherjee M, Tan NS, Huang C, Kim B, Radford K, Ju X, Venegas Garrido C, Kjarsgaard M, Rodríguez-Suárez E, Wechsler ME, Walker B, Börjesson Sjö L, Necander S, Ashkar A, Weidner J, Sehmi R, McCrae C, Khalidi N, Nair P.   +18 more
europepmc   +1 more source

Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study. [PDF]

Biomedicines
Piazzetta GL, Di Agostino S, Lobello N, Aloisio A, Di Vito A, Bria J, Filardo A, Coscarella I, Preianò M, Pelaia C, Lombardo N, Chiarella E.   +11 more
europepmc   +1 more source

Six-Month Benralizumab Maintenance for Relapsing Chronic Eosinophilic Pneumonia Guided by Eosinophil Kinetics. [PDF]

Respirol Case Rep
Sumi T, Ishigooka T, Takeda K, Naraoka T, Shijubou N, Yamada Y, Chiba H.   +6 more
europepmc   +1 more source

A Case of Eosinophilic Granulomatosis with Polyangiitis Emerging During Benralizumab Therapy: Successful Management Through a Switch to Mepolizumab Therapy. [PDF]

J Asthma Allergy
Saito Y, Ito J, Watanabe T, Tanabe Y, Sasano H, Sato Y, Jingo K, Nishimaki T, Matsuno K, Takahashi K, Harada N.   +10 more
europepmc   +1 more source

Benralizumab for anti-tumor necrosis factor-associated eosinophilic gastrointestinal disease in a child with ileal Crohn's: A case report. [PDF]

JPGN Rep
Dudzik J, Pinzon-Charry A, Lewindon P, Balouch F.   +3 more
europepmc   +1 more source

Comment on: Eosinophilic granulomatosis with polyangiitis across the eosinophilic spectrum: from molecular mechanisms to practical differential diagnosis and targeted therapy. [PDF]

Reumatologia
Kosałka-Węgiel J, Korkosz M.
europepmc   +1 more source